Abstract:Regenerative medicine (RM) has emerged as a promising and revolutionary solution to address a range of unmet needs in healthcare, including ophthalmology. Moreover, RM takes advantage of the body's innate ability to repair and replace pathologically affected tissues. On the other hand, despite its immense promise, RM faces challenges such as ethical concerns, host-related immune responses, and the need for additional scientific validation, among others. The primary aim of this review is to present a high-level overview of current strategies in the domain of RM (cell therapy, exosomes, scaffolds, in vivo reprogramming, organoids, and interspecies chimerism), centering around the field of ophthalmology. A search conducted on clinicaltrials.gov unveiled a total of at least 209 interventional trials related to RM within the ophthalmological field. Among these trials, there were numerous early-phase studies, including phase I, I/II, II, II/III, and III trials. Many of these studies demonstrate potential in addressing previously challenging and degenerative eye conditions, spanning from posterior segment pathologies like Age-related Macular Degeneration and Retinitis Pigmentosa to anterior structure diseases such as Dry Eye Disease and Limbal Stem Cell Deficiency. Notably, these therapeutic approaches offer tailored solutions specific to the underlying causes of each pathology, thus allowing for the hopeful possibility of bringing forth a treatment for ocular diseases that previously seemed incurable and significantly enhancing patients' quality of life. As advancements in research and technology continue to unfold, future objectives should focus on ensuring the safety and prolonged viability of transplanted cells, devising efficient delivery techniques, etc.

What problem does this paper attempt to address?

The paper primarily explores the application of Regenerative Medicine (RM) in the field of ophthalmology and its current research progress. As a promising and revolutionary solution, regenerative medicine aims to meet various unmet needs in healthcare, including ophthalmology. Specifically, the study covers the following aspects: 1. **Definition and Background of Regenerative Medicine**: Regenerative medicine refers to the technology of developing biological substitutes to restore, maintain, or improve the function of tissues or organs. It utilizes methods such as stem cells, tissue engineering, scaffold materials, soluble molecules, gene therapy, and the reprogramming of cell and tissue types. 2. **Overview of Current Strategies**: This paper reviews several major strategies in the field of regenerative medicine, including cell therapy, exosomes, scaffolds, in vivo reprogramming, organoids, and xenogeneic chimeras, with a focus on their applications in ophthalmology. 3. **Cell Therapy**: Cell therapy is based on the concept of transplanting autologous or allogeneic cells into patients to treat or manage diseases. This section discusses in detail the classification, characteristics, and clinical application potential of stem cells, particularly for the treatment of eye diseases. - **Categories of Stem Cells**: Including Embryonic Stem Cells (ESCs), Fetal Stem Cells (FSCs), and Adult Stem Cells (ASCs). Each type of stem cell has its unique advantages and limitations. - **Clinical Applications**: Stem cell therapy shows great potential in treating various eye diseases, such as age-related macular degeneration, retinitis pigmentosa, dry eye syndrome, and limbal stem cell deficiency. 4. **Challenges Faced**: Despite the great prospects of regenerative medicine, it still faces challenges such as ethical issues, host-related immune responses, and the need for more scientific validation. 5. **Future Directions**: With the advancement of research and technology, future studies should focus on ensuring the safety and long-term viability of transplanted cells, as well as developing effective delivery techniques. In summary, this paper provides a comprehensive overview of the application of regenerative medicine in the field of ophthalmology, highlighting the current state of development and possible future directions in this area.

Beyond Vision: An Overview of Regenerative Medicine and Its Current Applications in Ophthalmological Care

Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges

Ex-vivo ocular surface stem cell therapies: current techniques, applications, hurdles and future directions

Stem cell-based therapies for retinal diseases: focus on clinical trials and future prospects

Tissue Engineering Strategies for Retina Regeneration

Novel vision restoration techniques: 3D bioprinting, gene and stem cell therapy, optogenetics, and the bionic eye

Status and prospects for the development of regenerative therapies for corneal and ocular diseases

Regeneration of the Retina Using Pluripotent Stem Cells: A Comprehensive Review

Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges

Exploring Stem-Cell-Based Therapies for Retinal Regeneration

Innovative Bioscaffolds in Stem Cell and Regenerative Therapies for Corneal Pathologies

Cell-based Therapies for Corneal and Retinal Disorders

Empowering Mesenchymal Stem Cells for Ocular Degenerative Disorders

Stem Cell Therapy for Corneal Regeneration Medicine and Contemporary Nanomedicine for Corneal Disorders

Bioengineering strategies for restoring vision

Cell Therapy for Retinal Degenerative Diseases: Progress and Prospects

New Perspectives in Stem Cell Transplantation and Associated Therapies to Treat Retinal Diseases: From Gene Editing to 3D Bioprinting

Advances in retinal pigment epithelial cell transplantation for retinal degenerative diseases

Evaluating the Past, Present, and Future of Regenerative Medicine: A Global View

Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases

In situ Tissue Regeneration in the Cornea from Bench to Bedside